Ship Healthcare Holdings, Inc. (TYO:3360)

Ship Healthcare Holdings Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	23,106	24,328	21,860	20,665	20,804
Depreciation & Amortization	7,241	7,369	7,439	7,450	5,488
Loss (Gain) From Sale of Assets	158	464	2,719	27	484
Loss (Gain) From Sale of Investments	-21	-	1,261	-	-
Loss (Gain) on Equity Investments	-613	-1,091	-725	5	-357
Other Operating Activities	-8,986	-6,410	-8,744	-8,493	-9,075
Change in Accounts Receivable	-6,031	-11,026	1,436	-15,161	-97
Change in Inventory	343	-2,081	-1,801	-3,825	-3,325
Change in Accounts Payable	7,132	10,016	7,958	12,160	-1,645
Change in Other Net Operating Assets	-251	-1,185	206	1,277	151
Operating Cash Flow	22,078	20,384	31,609	14,105	12,428
Operating Cash Flow Growth	8.31%	-35.51%	124.10%	13.49%	-37.14%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-4,281	-3,821	-3,193	-3,469	-3,124
Sale of Property, Plant & Equipment	89	237	463	203	70
Cash Acquisitions	393	-120	-3,628	-3,110	-313
Divestitures	977	462	-1,911	-	-
Sale (Purchase) of Intangibles	-434	-361	-323	-439	-346
Investment in Securities	646	-795	827	-221	-53
Other Investing Activities	-250	46	34	-10	-82
Investing Cash Flow	-2,075	-4,025	-7,202	-6,774	-3,870

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	11	-	-	-	1,014
Long-Term Debt Issued	776	593	15,510	10,254	299
Total Debt Issued	787	593	15,510	10,254	1,313
Short-Term Debt Repaid	-	-10	-1,095	-788	-
Long-Term Debt Repaid	-6,136	-19,495	-30,662	-5,497	-6,056
Total Debt Repaid	-6,136	-19,505	-31,757	-6,285	-6,056
Net Debt Issued (Repaid)	-5,349	-18,912	-16,247	3,969	-4,743
Repurchase of Common Stock	-4,999	-	-	-	-
Common Dividends Paid	-5,472	-4,717	-3,962	-3,868	-3,774
Other Financing Activities	-514	-993	-273	-1,123	-325
Financing Cash Flow	-16,334	-24,622	-20,482	-1,022	-8,842

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	73	-7	182	-91	130
Miscellaneous Cash Flow Adjustments	4	-	-	-2	8
Net Cash Flow	3,746	-8,270	4,107	6,216	-146

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	17,797	16,563	28,416	10,636	9,304
Free Cash Flow Growth	7.45%	-41.71%	167.17%	14.32%	-38.55%
Free Cash Flow Margin	2.48%	2.44%	4.50%	1.86%	1.81%
Free Cash Flow Per Share	191.58	175.55	301.18	102.35	89.56
Levered Free Cash Flow	19,251	19,965	29,411	15,309	7,463
Unlevered Free Cash Flow	19,518	20,276	29,692	15,574	7,640

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	458	501	446	426	284
Cash Income Tax Paid	9,468	6,694	8,953	8,637	9,170
Change in Working Capital	1,193	-4,276	7,799	-5,549	-4,916

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 3, 2026

Data Sources Report a data error